UK Markets closed

Sarepta Therapeutics, Inc. (SRPT)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
109.34-3.73 (-3.30%)
As of 03:31PM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Jun 2022)Next qtr. (Sep 2022)Current year (2022)Next year (2023)
No. of analysts12121515
Avg. Estimate-1.18-1.07-4.63-3.54
Low estimate-1.7-1.65-6.1-6.42
High estimate-0.88-0.43-3.55-1.08
Year ago EPS-1.02-0.6-5.15-4.63
Revenue estimateCurrent qtr. (Jun 2022)Next qtr. (Sep 2022)Current year (2022)Next year (2023)
No. of analysts15151818
Avg. Estimate220.81M230.55M899.91M1.06B
Low estimate215M225M882.2M928M
High estimate226.2M237.3M919.43M1.27B
Year ago salesN/A189.41M701.89M899.91M
Sales growth (year/est)N/A21.70%28.20%17.20%
Earnings history29/06/202129/09/202130/12/202130/03/2022
Est. EPS-1.28-1.89-1.13-1.27
Actual EPS-1.02-0.6-1.42-1.2
Difference0.261.29-0.290.07
Surprise %20.30%68.30%-25.70%5.50%
EPS trendCurrent qtr. (Jun 2022)Next qtr. (Sep 2022)Current year (2022)Next year (2023)
Current estimate-1.18-1.07-4.63-3.54
7 days ago-1.18-1.07-4.65-3.39
30 days ago-1.18-1.07-4.64-3.37
60 days ago-1.16-1.01-4.53-3.39
90 days ago-1.29-1.16-4.9-3.72
EPS revisionsCurrent qtr. (Jun 2022)Next qtr. (Sep 2022)Current year (2022)Next year (2023)
Up last 7 daysN/A11N/A
Up last 30 daysN/A112
Down last 7 daysN/AN/AN/AN/A
Down last 30 days1N/AN/A1
Growth estimatesSRPTIndustrySector(s)S&P 500
Current qtr.-15.70%N/AN/AN/A
Next qtr.-78.30%N/AN/AN/A
Current year10.10%N/AN/AN/A
Next year23.50%N/AN/AN/A
Next 5 years (per annum)96.00%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A